tradingkey.logo

Ekso Bionics Holdings Inc

EKSO
10.410USD
+1.050+11.22%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
27.31MMarktkapitalisierung
VerlustKGV TTM

Ekso Bionics Holdings Inc

10.410
+1.050+11.22%

mehr Informationen über Ekso Bionics Holdings Inc Unternehmen

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Ekso Bionics Holdings Inc Informationen

BörsenkürzelEKSO
Name des UnternehmensEkso Bionics Holdings Inc
IPO-datumApr 10, 2013
CEODavis (Scott G)
Anzahl der mitarbeiter61
WertpapierartOrdinary Share
GeschäftsjahresendeApr 10
Addresse101 Glacier Point
StadtSAN RAFAEL
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94901
Telefon15109841761
Websitehttps://eksobionics.com/
BörsenkürzelEKSO
IPO-datumApr 10, 2013
CEODavis (Scott G)

Führungskräfte von Ekso Bionics Holdings Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+15747.00%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
18.59K
-1320.00%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.56K
-1238.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
+15747.00%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+15747.00%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
18.59K
-1320.00%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.56K
-1238.00%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
+15747.00%
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
3.16M
74.78%
Other EMEA
428.00K
10.13%
France
363.00K
8.59%
APAC
253.00K
5.99%
Other Americas
22.00K
0.52%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Asher (Daniel)
19.98%
Davis (Scott Gerald)
2.33%
Citadel Advisors LLC
1.14%
The Vanguard Group, Inc.
1.04%
Li (Kecheng)
0.91%
Andere
74.61%
Aktionäre
Aktionäre
Anteil
Asher (Daniel)
19.98%
Davis (Scott Gerald)
2.33%
Citadel Advisors LLC
1.14%
The Vanguard Group, Inc.
1.04%
Li (Kecheng)
0.91%
Andere
74.61%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
26.52%
Investment Advisor
1.86%
Hedge Fund
1.57%
Investment Advisor/Hedge Fund
0.97%
Research Firm
0.33%
Family Office
0.03%
Andere
68.71%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
64
261.39K
8.72%
--
2025Q3
67
261.39K
11.41%
+205.54K
2025Q2
64
55.85K
14.40%
-195.55K
2025Q1
62
251.40K
15.39%
-37.98K
2024Q4
61
283.25K
26.99%
-87.09K
2024Q3
58
370.34K
18.68%
+159.85K
2024Q2
61
145.58K
14.28%
+25.92K
2024Q1
67
120.72K
11.67%
-18.52K
2023Q4
71
95.15K
14.09%
+2.45K
2023Q3
71
92.88K
16.51%
-13.62K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Davis (Scott Gerald)
78.95K
2.33%
+56.69K
+254.58%
Nov 10, 2025
Citadel Advisors LLC
38.55K
1.14%
+38.55K
--
Sep 30, 2025
The Vanguard Group, Inc.
35.45K
1.04%
+23.49K
+196.31%
Sep 30, 2025
Li (Kecheng)
30.73K
0.91%
+15.75K
+105.11%
May 16, 2025
Lathan (Corinna)
25.61K
0.75%
+15.75K
+159.61%
May 16, 2025
Cloyd (Mary Ann)
25.23K
0.74%
+15.75K
+166.00%
May 16, 2025
DRW Securities, LLC
20.19K
0.6%
+20.19K
--
Sep 30, 2025
Jones (Jason C)
19.91K
0.59%
-270.00
-1.34%
Dec 09, 2025
Cresset Asset Management, LLC
17.96K
0.53%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
May 19, 2025
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Datum
Ex-Dividendentag
Art
Verhältnis
May 19, 2025
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
KeyAI